Press Release
Category Added in a WPeMatico Campaign
-
Business Wire8 November 2025
New Post Hoc Analysis from the HELIOS-B Phase 3 Study Shows Vutrisiran Improved Measures of Heart Structure and Function in Patients with ATTR-CM
− Analyses Presented at the American Heart Association Scientific Sessions 2025 Underscore Vutrisiran’s Differentiated Profile – − Cardiovascular Magnetic Resonance…
Read More » -
Business Wire8 November 2025
United States Otorhinolaryngology KOLs Fair-Market Value Compensation Rates Report 2025: An Independent Reference for Negotiations with Thought Leaders (KOLs) and Healthcare Providers (HCPs) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “United States Fair-Market Value Compensation Rates for Otorhinolaryngology KOLs” report has been added to ResearchAndMarkets.com’s offering. This report…
Read More » -
Business Wire8 November 2025
Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Phase 3 CORALreef Lipids Trial
Enlicitide, designed to deliver antibody-like efficacy, has the potential to be the first approved oral PCSK9 inhibitor to lower LDL-C…
Read More » -
Business Wire8 November 2025
Real Reaches Settlement in Principle in Litigation With Former CFO
MIAMI–(BUSINESS WIRE)–The Real Brokerage Inc. (NASDAQ: REAX), a leading real estate technology platform redefining the industry through innovation and culture,…
Read More » -
Business Wire8 November 2025
FIS Launches Innovative Asset Servicing Management Suite to Unlock Operational Efficiency Across Asset Servicing
Key facts FIS Asset Servicing Management Suite helps capital investment work harder by unlocking operational efficiencies across all areas of…
Read More » -
Cision PR Newswire8 November 2025
Zinzino AB (publ.): Zinzino acquires Mexican company Sanki to increase distribution capacity in North America and South America
GOTHENBURG, Sweden, Nov. 8, 2025 /PRNewswire/ — Zinzino has signed an agreement with Mexico-based direct sales company Sanki to acquire…
Read More » -
Cision PR Newswire8 November 2025AMGEN’S REPATHA® CUTS RISK OF FIRST MAJOR ADVERSE CARDIOVASCULAR EVENTS BY 25% IN LANDMARK PHASE 3 VESALIUS-CV TRIAL
Study Also Shows 36% Reduction in Risk of Heart Attack Repatha is the First and Only PCSK9 Inhibitor to Significantly…
Read More » -
Cision PR Newswire8 November 2025Vaughn College Hosts 11th Annual Manufacturing Day to Promote Career Opportunities and to Inspire the Next Generation of Engineering and Technology Professionals
The annual event hosted by Vaughn’s Engineering and Technology Department featuredpresentations from industry experts and STEM workshops for local community…
Read More » -
Business Wire8 November 2025
Groundbreaking pivotal study results of olezarsen for severe hypertriglyceridemia (sHTG) presented as a late breaker at AHA Scientific Sessions
– Up to 72% placebo-adjusted mean reduction in fasting triglyceride levels at six months, with reductions sustained through 12 months…
Read More » -
Business Wire8 November 2025
Westinghouse and Hungary Establish Landmark Nuclear Fuel Partnership
First Contract Signed with MVM Group to Deliver VVER-440 Fuel to Paks Nuclear Power Plant WASHINGTON–(BUSINESS WIRE)–Westinghouse Electric Company and…
Read More »